Privately-held Sebacia Inc. said today that it closed a $20 million Series D financing round, led by existing investors Versant Ventures, Domain Associates, Accuitive Medical Ventures and Partners Healthcare Innovation Fund.
New investors, including Salem Partners, also joined the round. The Duluth, Ga.-based company also said it closed a $16 million debt facility with Hercules Capital.
Get the full story at our sister site, Drug Delivery Business News.
The post Sebacia raises $36m for microparticle acne treatment appeared first on MassDevice.
from MassDevice http://ift.tt/2tzIW7H
Cap comentari:
Publica un comentari a l'entrada